Yang Y - Search Results

1

Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma.

Xiong Y, Liu L, Xia Y, Qi Y, Chen Y, Chen L, Zhang P, Kong Y, Qu Y, Wang Z, Lin Z, Chen X, Xiang Z, Wang J, Bai Q, Zhang W, Yang Y, Guo J, Xu J. Xiong Y, et al. Among authors: yang y. Cancer Immunol Immunother. 2019 May;68(5):731-741. doi: 10.1007/s00262-019-02314-y. Epub 2019 Feb 13. Cancer Immunol Immunother. 2019. PMID: 30758643 Free PMC article.

2

CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma.

Chen X, Liu L, Wang J, Lin Z, Xiong Y, Qu Y, Wang Z, Yang Y, Guo J, Xu J. Chen X, et al. Among authors: yang y. Urol Oncol. 2018 May;36(5):242.e15-242.e21. doi: 10.1016/j.urolonc.2017.12.023. Epub 2018 Jan 19. Urol Oncol. 2018. PMID: 29370961

3

P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.

Liu Z, Liu Y, Xu L, An H, Chang Y, Yang Y, Zhang W, Xu J. Liu Z, et al. Among authors: yang y. Cancer Sci. 2015 Sep;106(9):1224-31. doi: 10.1111/cas.12736. Epub 2015 Jul 29. Cancer Sci. 2015. PMID: 26179886 Free PMC article.

4

IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.

Wang Z, Xu L, Chang Y, Zhou L, Fu H, Zhang W, Yang Y, Xu J. Wang Z, et al. Among authors: yang y. Tumour Biol. 2016 Aug;37(8):11127-34. doi: 10.1007/s13277-016-4879-3. Epub 2016 Mar 1. Tumour Biol. 2016. PMID: 26926076

5

p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma.

Liu W, Yang Y, Liu Y, Liu H, Zhang W, Xu L, Zhu Y, Xu J. Liu W, et al. Among authors: yang y. Urol Oncol. 2015 May;33(5):205.e13-21. doi: 10.1016/j.urolonc.2015.01.024. Epub 2015 Mar 2. Urol Oncol. 2015. PMID: 25744653

6

High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma.

Xu L, Chang Y, An H, Zhu Y, Yang Y, Xu J. Xu L, et al. Among authors: yang y. Urol Oncol. 2015 Aug;33(8):340.e1-8. doi: 10.1016/j.urolonc.2015.05.009. Epub 2015 Jun 4. Urol Oncol. 2015. PMID: 26051357

7

CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.

An H, Xu L, Chang Y, Zhu Y, Yang Y, Chen L, Lin Z, Xu J. An H, et al. Among authors: yang y. Eur J Cancer. 2015 Sep;51(14):1953-61. doi: 10.1016/j.ejca.2015.06.125. Epub 2015 Jul 15. Eur J Cancer. 2015. PMID: 26188847

8

The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.

Zhou L, Chang Y, Xu L, Liu Z, Fu Q, Yang Y, Lin Z, Xu J. Zhou L, et al. Among authors: yang y. J Urol. 2016 Aug;196(2):335-42. doi: 10.1016/j.juro.2016.02.2971. Epub 2016 Mar 10. J Urol. 2016. PMID: 26970566

9

Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma.

Chang Y, Xu L, Zhou L, Fu Q, Liu Z, Yang Y, Lin Z, Xu J. Chang Y, et al. Among authors: yang y. Oncotarget. 2016 Apr 26;7(17):24527-36. doi: 10.18632/oncotarget.8235. Oncotarget. 2016. PMID: 27016418 Free PMC article.

10

Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma.

Fu H, Liu Y, Xu L, Chang Y, Zhou L, Zhang W, Yang Y, Xu J. Fu H, et al. Among authors: yang y. Medicine (Baltimore). 2016 Apr;95(17):e3225. doi: 10.1097/MD.0000000000003225. Medicine (Baltimore). 2016. PMID: 27124015 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110,490 results

Search Page

Filters